Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 36.27B | 32.68B | 31.10B | 27.81B | 25.77B |
Gross Profit | 8.12B | 7.15B | 6.80B | 6.67B | 6.38B |
EBITDA | 4.47B | 3.57B | 2.96B | 2.58B | 1.92B |
Net Income | 2.39B | 1.78B | 1.40B | 1.05B | 747.76M |
Balance Sheet | |||||
Total Assets | 22.49B | 20.06B | 17.52B | 16.24B | 16.80B |
Cash, Cash Equivalents and Short-Term Investments | 5.68B | 5.92B | 5.07B | 4.91B | 5.02B |
Total Debt | 1.95B | 2.55B | 2.13B | 2.72B | 3.45B |
Total Liabilities | 8.87B | 8.05B | 7.09B | 6.79B | 7.39B |
Stockholders Equity | 13.55B | 11.95B | 10.38B | 9.40B | 9.37B |
Cash Flow | |||||
Free Cash Flow | 3.39B | 1.21B | 1.51B | 1.68B | -796.40M |
Operating Cash Flow | 3.56B | 1.42B | 1.65B | 1.84B | -607.39M |
Investing Cash Flow | -2.28B | -233.18M | -360.39M | -9.40M | -612.07M |
Financing Cash Flow | -1.51B | -432.38M | -1.28B | -1.89B | 1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥37.36B | 16.49 | 2.60% | 11.00% | 33.93% | ||
77 Outperform | ¥27.14B | 11.28 | 1.14% | 11.94% | 14.10% | ||
77 Outperform | ¥56.72B | 14.96 | 2.56% | 9.68% | -2.04% | ||
74 Outperform | ¥23.93B | 33.08 | 1.76% | 7.60% | -6.99% | ||
73 Outperform | ¥34.31B | 13.18 | 7.79% | 4.93% | 2.87% | 4.34% | |
69 Neutral | ¥34.74B | 14.76 | 3.17% | 0.01% | 35.73% | ||
68 Neutral | ¥234.20B | 14.88 | 7.50% | 2.60% | 9.27% | 5.76% |